Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
Checkpoint Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Checkpoint Therapeutics reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, two executives at Checkpoint Therapeutics received on average a compensation package of $1.5M, a 4% increase compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $2.3M in total, which decreased by 1% compared to 2019. 64% of Oliviero's compensation, or $1.5M, was in stock awards. Oliviero also received $319K in non-equity incentive plan and $515K in salary.
William Garrett Gray, Chief Financial Officer, received a compensation package of $678K, which increased by 25% compared to previous year. 56% of the compensation package, or $382K, was in stock awards.
Related executives
You may also like
Source: SEC filing on April 30, 2021.